Cargando…
Cardiac Microvascular Endothelial Enhancement of Cardiomyocyte Function Is Impaired by Inflammation and Restored by Empagliflozin
The positive findings of the EMPA-REG OUTCOME trial (Randomized, Placebo-Controlled Cardiovascular Outcome Trial of Empagliflozin) on heart failure (HF) outcome in patients with type 2 diabetes mellitus suggest a direct effect of empagliflozin on the heart. These patients frequently have HF with pre...
Autores principales: | Juni, Rio P., Kuster, Diederik W.D., Goebel, Max, Helmes, Michiel, Musters, René J.P., van der Velden, Jolanda, Koolwijk, Pieter, Paulus, Walter J., van Hinsbergh, Victor W.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872802/ https://www.ncbi.nlm.nih.gov/pubmed/31768475 http://dx.doi.org/10.1016/j.jacbts.2019.04.003 |
Ejemplares similares
-
Large-Scale Contractility Measurements Reveal Large Atrioventricular and Subtle Interventricular Differences in Cultured Unloaded Rat Cardiomyocytes
por: Nollet, Edgar E., et al.
Publicado: (2020) -
End‐diastolic force pre‐activates cardiomyocytes and determines contractile force: role of titin and calcium
por: Najafi, Aref, et al.
Publicado: (2019) -
High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes
por: Verkaik, Melissa, et al.
Publicado: (2018) -
Dysregulation of cardiac endothelial lncRNA H19 in COVID19 patients induces endothelial dysfunction, which impairs cardiomyocyte function
por: Juni, Rio, et al.
Publicado: (2022) -
Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy
por: Bollen, Ilse A. E., et al.
Publicado: (2017)